chr18-45627041-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_007163.4(SLC14A2):āc.415C>Gā(p.Leu139Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,316 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_007163.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLC14A2 | NM_007163.4 | c.415C>G | p.Leu139Val | missense_variant | 4/20 | ENST00000255226.11 | |
LOC105372093 | XR_935423.3 | n.1207+9782G>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLC14A2 | ENST00000255226.11 | c.415C>G | p.Leu139Val | missense_variant | 4/20 | 1 | NM_007163.4 | P1 | |
SLC14A2 | ENST00000586448.5 | c.415C>G | p.Leu139Val | missense_variant | 5/21 | 2 | P1 | ||
SLC14A2 | ENST00000323329.3 | c.415C>G | p.Leu139Val | missense_variant, NMD_transcript_variant | 4/11 | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461316Hom.: 0 Cov.: 33 AF XY: 0.00000275 AC XY: 2AN XY: 726936
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 13, 2023 | The c.415C>G (p.L139V) alteration is located in exon 4 (coding exon 3) of the SLC14A2 gene. This alteration results from a C to G substitution at nucleotide position 415, causing the leucine (L) at amino acid position 139 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at